Halper Sadeh Investigates Forte Biosciences and Safety Insurance Sales for Shareholder Fairness

GlobeNewswire··Read original
2▲0 ▼0Impact / 5
Summary · why it matters

Halper Sadeh LLC is investigating whether the proposed sales of Forte Biosciences and Safety Insurance Group are fair to shareholders. Forte Biosciences is being sold to argenx for $77.00 per share in cash, while Safety Insurance Group is being sold to an affiliate of Mapfre S.A. for $105.00 per share in cash. The law firm is examining potential violations of federal securities laws and breaches of fiduciary duties, noting that insiders may receive substantial financial benefits not available to ordinary shareholders and that the proposed transactions may contain terms that could limit superior competing offers. Halper Sadeh may seek increased consideration, additional disclosures, or other relief on behalf of shareholders.

Impact on assets 4

Financials▲ · 2 stocks
Safety Insurance Group Inc
SAFT
± MixedCapitalrelevance

Safety Insurance is being acquired for $105/share; investigation may increase consideration or block deal, but outcome uncertain.

Biotech & Genomic Medicine▲ · 1 stocks
Forte Biosciences Inc
FBRX
± MixedCapitalrelevance

Forte Biosciences is being acquired for $77/share; investigation may increase consideration or block deal, but outcome uncertain.

Health Care▲ · 1 stocks
© 2026 MarketIVNews